| COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study LYW Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ... The Lancet 395 (10241), 1919-1926, 2020 | 1215 | 2020 |
| COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ... The Lancet Oncology 21 (10), 1309-1316, 2020 | 631 | 2020 |
| Future directions in the treatment of osteosarcoma A Smrke, PM Anderson, A Gulia, S Gennatas, PH Huang, RL Jones Cells 10 (1), 172, 2021 | 131 | 2021 |
| Telemedicine during the COVID-19 pandemic: impact on care for rare cancers A Smrke, E Younger, R Wilson, O Husson, S Farag, E Merry, ... JCO global oncology 6, 1046-1051, 2020 | 107 | 2020 |
| Health-related quality of life and experiences of sarcoma patients during the COVID-19 pandemic E Younger, A Smrke, E Lidington, S Farag, K Ingley, N Chopra, ... Cancers 12 (8), 2288, 2020 | 61 | 2020 |
| Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study A Fendler, L Au, STC Shepherd, F Byrne, M Cerrone, LA Boos, ... Nature Cancer 2 (12), 1321-1337, 2021 | 59 | 2021 |
| Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19 C Várnai, C Palles, R Arnold, HM Curley, K Purshouse, VWT Cheng, ... JAMA network open 5 (2), e220130-e220130, 2022 | 53 | 2022 |
| Breast cancer in association with thyroid disorders V Michalaki, A Kondi-Pafiti, S Gennatas, A Antoniou, H Primetis, ... J buon 14 (3), 425-8, 2009 | 41 | 2009 |
| Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer V Angelis, Z Tippu, K Joshi, S Reis, F Gronthoud, C Fribbens, A Okines, ... European Journal of Cancer 136, 99-106, 2020 | 37 | 2020 |
| Low-grade fibromyxoid sarcoma: treatment outcomes and efficacy of chemotherapy F Chamberlain, B Engelmann, O Al-Muderis, C Messiou, K Thway, A Miah, ... in vivo 34 (1), 239-245, 2020 | 36 | 2020 |
| A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice M Linch, S Gennatas, S Kazikin, J Iqbal, R Gunapala, K Priest, J Severn, ... BMC cancer 14, 1-7, 2014 | 33 | 2014 |
| Trastuzumab plus capecitabine and docetaxel as first-line therapy for HER2-positive metastatic breast cancer: phase II results V Michalaki, S Fotiou, S Gennatas, C Gennatas Anticancer research 30 (7), 3051-3054, 2010 | 27 | 2010 |
| Adjuvant imatinib in patients with GIST harboring exon 9 KIT mutations: results from a multi-institutional European retrospective study B Vincenzi, A Napolitano, M Fiocco, O Mir, P Rutkowski, JY Blay, ... Clinical Cancer Research 28 (8), 1672-1679, 2022 | 26 | 2022 |
| Patterns of relapse in extrapulmonary small cell carcinoma: retrospective analysis of outcomes from two cancer centres S Gennatas, J Noble, S Stanway, R Gunapala, R Chowdhury, ... BMJ open 5 (1), e006440, 2015 | 26 | 2015 |
| Adult soft tissue myoepithelial carcinoma: treatment outcomes and efficacy of chemotherapy F Chamberlain, E Cojocaru, M Scaranti, J Noujaim, A Constantinou, ... Medical Oncology 37, 1-8, 2020 | 25 | 2020 |
| Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre F Chamberlain, S Farag, C Williams-Sharkey, C Collingwood, L Chen, ... Clinical sarcoma research 10, 1-8, 2020 | 22 | 2020 |
| COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE) L Castelo-Branco, Z Tsourti, S Gennatas, J Rogado, M Sekacheva, ... ESMO open 7 (3), 100499, 2022 | 21 | 2022 |
| UK Coronavirus Monitoring Project Team: COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: A prospective cohort study LY Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ... Lancet 395 (10/241), 1919-1926, 2020 | 20 | 2020 |
| Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma S Gennatas, SJ Stanway, R Thomas, T Min, R Shah, MER O’Brien, ... BMC cancer 13, 1-4, 2013 | 19 | 2013 |
| Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results V Michalaki, S Gennatas, K Gennatas Anti-cancer drugs 20 (3), 204-207, 2009 | 19 | 2009 |
